Physician profile
Travis Bowen
NPI 1629569223
$2,282.69
in general payments reported to CMS, 2019-2025
13 companies · $1,199 in 2025
The $1,199 reported for 2025 was more than what 91% of Sports Medicine (Family Medicine) providers received nationally (typical 2025 total: $113).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $24.63 · 2023: $916 · 2024: $143 · 2025: $1,199.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,547 · Food and Beverage: $711.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,547.34 |
| Food and Beverage | $710.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $916.81 | 2022-2025 | Iovera, Zilretta |
| Prime Surgical, LLC | $700.81 | 2025 | |
| Arthrex, INC. | $288.20 | 2025 | |
| Radius Health, INC. | $95.40 | 2023-2024 | Tymlos |
| Abbott Laboratories | $55.72 | 2024-2025 | Eterna |
| Djo, LLC | $49.49 | 2023 | Cmf |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $45.23 | 2025 | Relistor |
| Valinor Pharma, LLC | $31.16 | 2025 | Movantik |
| Nalu Medical, INC. | $22.77 | 2025 | Nalu Neurostimulation System |
| Medtronic, INC. | $20.96 | 2024 | Kyphon Express II Kyphopak Tray |
| Almatica Pharma LLC | $20.08 | 2025 | Teriparatide |
| Vertex Pharmaceuticals Incorporated | $18.20 | 2025 | |
| Abbvie INC. | $17.86 | 2023 | Botox |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Travis Bowen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.